Patent Assignment
Reel/Frame 041660/0644
Change of Name
Recorded: 2017-02-08
Pages: 5
Assignor
EDISON PHARMACEUTICALS, INC.
Executed: 2017-01-17
Assignee
BIOELECTRON TECHNOLOGY CORPORATION
350 NORTH BERNARDO AVENUE, MOUNTAIN VIEW, CALIFORNIA, 94043
Covered Properties
(66)
Quinones for Protection Against Radiation Exposure
PCT:
PCT/US2015/063824 ↗
Methods for Chiral Resolution of Trolox
PCT:
PCT/US2015/066208 ↗
Polymorphic and Amorphous Forms of (R)-2-Hydroxy-2-Methyl-4-(2,4-5-Trimethyl-3,6-Dioxocyclohexa-1, 4-Dienyl) Butanami De
PCT:
PCT/US2015/066211 ↗
Improved Methods for Enriching Alpha-Tocotrienol from Mixed Tocol Compositions
PCT:
PCT/US2016/067377 ↗
Flouroalkyl, Flouroalkoxy, Phenoxy, Heteroaryloxyl, Alkoxy, and Amine 1,4-Benzoquinone Derivatives for Treatment of Oxidative Stress Disorders
PCT:
PCT/US2016/067404 ↗
Methods for Diagnosing and Treating Oxidative Stress Disorders Using Biomarkers
PCT:
PCT/US2017/013268 ↗
Tocopherol and Tocotrienol Quinone Derivatives for Increasing Thiosulfate Levels or Decreasing Hydrogen Sulfide Levels
PCT:
PCT/US2017/013271 ↗
Alkyl- , Acyl-, Urea-, and Aza-Uracil Sulfide:Quinone Oxidoreductase Inhibitors
PCT:
PCT/US2017/013273 ↗
Methods for the Prevention and Treatment of Cerebral Ischemia Using Non-Alpha Tocopherols
Identifying Therapeutic Compounds Based on Their Physical-Chemical Properties
7,8-Bicycloalkyl-Chroman Derivatives
Chroman Derivatives
Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
Tail Variants of Redox-Active Therapeutics for Treatment of Mitochondrial Diseases and Other Conditions and Modulation of Energy Biomarkers
Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
4-(P-Quinonyl)-2-Hydroxybutanamide Derivatives for Treatment of Mitochondrial Diseases
7,8-Bicycloakyl-Chroman Derivatives
Chroman Derivatives
Treatment of Pervasive Developmental Disorders with Redox-Active Therapeutics
Process for the Production of Alpha-Tocotrienol and Derivatives
Redox-Active Therapeutics for Treatment of Mitochondrial Diseases and Other Conditions and Modulation of Energy Biomarkers
(Het)Aryl-P-Quinone Derivatives for Treatment of Mitochondrial Diseases
2-Substituted-P-Quinone Derivatives for Treatment of Oxidative Stress Diseases
2-Heterocyclylaminoalkyl-(P-Quinone) Derivatives for Treatment of Oxidative Stress Diseases
4-(P-Quinonyl)-2-Hydroxybutanamide Derivatives for Treatment of Mitochondrial Diseases
Treatment of Oxidative Stress Disorders Including Contrast Nephropathy, Radiation Damage and Disruptions in the Function of Red Cells
Chroman Derivatives
Process for the Production of Alpha-Tocotrienol and Derivatives
Treatment of Pervasive Developmental Disorders with Redox-Active Therapeutics
Formulations of Tocotrienol Quinones for the Treatment of Ophthalmic Diseases
Application:
13/738,827 →
Publication:
US 2014/0031433
Treatment of Mitochondrial Diseases with Naphthoquinones
Application:
13/814,721 →
Publication:
US 2013/0345312
Resorufin Derivatives for Treatment of Oxidative Stress Disorders
Phenazine-3-One and Phenothiazine-3-One Derivatives for Treatment of Oxidative Stress Disorders
Application:
13/838,372 →
Publication:
US 2014/0275045
Treatment of Leber's Hereditary Optic Neuropathy and Dominant Optic Atrophy with Tocotrienol Quinones
4-(P-Quinonyl)-2-Hydroxybutanamide Derivatives for Treatment of Mitochondrial Diseases
Catechol Derivatives for Treatment of Oxidative Stress Diseases
Treatment of Methylmalonic Aciduria, Isovaleric Aciduria, and Other Organic Acidurias with Tocotrienol Quinones
Application:
14/130,903 →
Publication:
US 2015/0057363
Treatment of Pervasive Developmental Disorders with Redox-Active Therapeutics
Treatment of Hearing and Balance Impairments with Redox-Active Therapeutics
Application:
14/174,753 →
Publication:
US 2014/0249160
2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES
2-Heterocyclylaminoalkyl-(P-Quinone) Derivatives for Treatment of Oxidative Stress Diseases
Methods for Oxidation of Alpha Tocotrienol in the Presence of Non-Alpha Tocotrienols
Quinone Derivatives for Use in the Modulation of Redox Status of Individuals
Application:
14/426,130 →
Publication:
US 2015/0216820
Benzoquinone Derivatives for Treating Oxidative Stress Disorders
(Het)Aryl-P-Quinone Derivatives for Treatment of Mitochondrial Diseases
Treatment of Pervasive Developmental Disorders with Redox-Active Therapeutics
Alkyl-Heteroaryl Substituted Quinone Derivatives for Treatment of Oxidative Stress Disorders
Resorufin Derivatives for Treatment of Oxidative Stress Disorders
Phenazine-3-One and Phenothiazine-3-One Derivatives for Treatment of Oxidative Stress Disorders
4-(p-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES
Methods for Oxidation of Alpha Tocotrienol in the Presence of Non-Alpha Tocotrienols
Carboxylic Acid Derivatives for Treatment of Oxidative Stress Disorders
Application:
14/894,277 →
Publication:
US 2016/0115141
Side-Chain Variants of Redox-Active Therapeutics for Treatment of Mitochondrial Diseases and Other Conditions and Modulation of Energy Biomarkers
Methods for the Prevention and Treatment of Cerebral Ischemia
Application:
15/040,961 →
Publication:
US 2017/0007553
Process for the Production of Alpha-Tocotrienol and Derivatives
Treatment of Leber's Hereditary Optic Neuropathy and Dominant Optic Atrophy with Tocotrienol Quinones
Treatment of Mitochondrial Diseases
Application:
15/189,948 →
Publication:
US 2016/0324823
Treatment of Pervasive Developmental Disorders with Redox-Active Therapeutics
Treatment of Leigh Syndrome and Leigh-Like Syndrome with Tocotrienol Quinones
Application:
15/288,834 →
Publication:
US 2017/0246124
4-(Pquinonyl)-2-Hydroxybutanamide Derivatives for Treatment of Mitochondrial Diseases
Formulations of Quinones for the Treatment of Ophthalmic Diseases
Application:
15/407,831 →
Publication:
US 2017/0354618
Methods for Selective Oxidation of Alpha Tocotrienol in the Presence of Non-Alpha Tocotrienols
Methods for enriching alpha-tocotrienol from mixed tocol compositions
Application:
62/386,943 →
Methods for enriching alpha-tocotrienol from mixed tocol compositions
Application:
62/386,949 →
Methods of Analyzing P-Hydroquinone Levels and Ratios
Application:
62/414,616 →
Aryl- and Heteroaryl-Resorufin Derivatives for Treatment of Oxidative Stress Disorders
Application:
62/443,641 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 18, 2002
From: MILLER, GUY MICHAEL; BROWN, LESLEY A.; DEL BALZO, UGHETTA; FLAIM, STEPHEN
To: GALILEO LABORATORIES, INC.
Reel/Frame 012736/0550 →
Change of Name
Jul 15, 2003
From: GALILEO LABORTORIES, INC.
To: GALILEO PHARMACEUTICALS, INC.
Reel/Frame 013805/0479 →
Assignment of Assignor's Interest
Jan 12, 2004
From: GILAT, SYLVAIN; BINYAMIN, GARY; MILLER, GUY
To: GALILEO PHARMACEUTICALS, INC.
Reel/Frame 014253/0239 →
Assignment of Assignor's Interest
Feb 3, 2004
From: KHANSARI, PARTO
To: GALILEO PHARMACEUTICALS, INC.
Reel/Frame 014303/0513 →
Assignment of Assignor's Interest
Jan 3, 2005
From: WANG, BING; WALKINSHAW, GAIL; CHEN, JIAN; JIN, XIANMING
To: GALILEO PHARMACEUTICALS, INC.
Reel/Frame 016123/0668 →
Assignment of Assignor's Interest
Jan 3, 2005
From: WANG, BING; WALKINSHAW, GAIL; CHEN, JIAN; BODDUPALLI, SEKHAR
To: GALILEO PHARMACEUTICALS, INC.
Reel/Frame 016123/0688 →
Security Agreement
Dec 22, 2005
From: GALILEO PHARMACEUTICALS, INC.
To: ALLOY VENTURES, INC.
Reel/Frame 016936/0079 →
Assignment of Assignor's Interest
Aug 15, 2006
From: MILLER, GUY M.; HECHT, SIDNEY M.
To: EDISON PHARMACEUTICALS, INC.
Reel/Frame 018126/0367 →
Release of Security Interest
Sep 7, 2006
From: ALLOY VENTURES, INC. AS SECURED PARTY AND AS COLLATERAL AGENT FOR ADDITIONAL SECURED PARTIES UNDER THE SECURED NOTE PURCHASE AGREEMENT DATED AS OF DECEMBER 22, 2005
To: GALILEO PHARMACEUTICALS, INC.
Reel/Frame 018229/0946 →
Assignment of Assignor's Interest
Sep 21, 2006
From: GALILEO PHARMACEUTICALS, INC.
To: EDISON PHARMACEUTICALS, INC.
Reel/Frame 018284/0533 →
Assignment of Assignor's Interest
Nov 30, 2006
From: MILLER, GUY M.; HECHT, SIDNEY M.
To: EDISON PHARMACEUTICALS, INC.
Reel/Frame 018568/0688 →
Release of Security Interest
Mar 14, 2007
From: ALLOY VENTURES, INC. AS SECURED PARTY AND AS COLLATERAL AGENT FOR ADDITIONAL SECURED PARTIES UNDER THE SECURED NOTE PURCHASE AGREEMENT DATED AS OF DECEMBER 22, 2005
To: GALILEO PHARMACEUTICALS, INC.
Reel/Frame 019009/0088 →
Assignment of Assignor's Interest
May 15, 2007
From: GALILEO PHARMACEUTICALS, INC.
To: EDISON PHARMACEUTICALS, INC.
Reel/Frame 019287/0820 →
Assignment of Assignor's Interest
May 25, 2007
From: MILLER, GUY M.; HECHT, SIDNEY M.; JANKOWSKI, ORION D.; WESSON, KIERON E.
To: EDISON PHARMACEUTICALS, INC.
Reel/Frame 019346/0954 →
Assignment of Assignor's Interest
May 30, 2007
From: GALILEO PHARMACEUTICALS, INC.
To: EDISON PHARMACEUTICALS, INC.
Reel/Frame 019357/0007 →
Assignment of Assignor's Interest
Jun 21, 2007
From: GALILEO PHARMACEUTICALS, INC.
To: EDISON PHARMACEUTICALS, INC.
Reel/Frame 019465/0734 →
Assignment of Assignor's Interest
Jan 8, 2009
From: JANKOWSKI, ORION D.; WESSON, KIERON E.; MOLLARD, PAUL; SHRADER, WILLIAM D.
To: EDISON PHARMACEUTICALS, INC.
Reel/Frame 022079/0847 →
Change of Name
Mar 26, 2009
From: GALILEO LABORATORIES, INC.
To: GALILEO PHARMACEUTICALS, INC.
Reel/Frame 022449/0847 →
Assignment of Assignor's Interest
Apr 2, 2009
From: GALILEO PHARMACEUTICALS, INC.
To: EDISON PHARMACEUTICALS, INC.
Reel/Frame 022496/0305 →
Assignment of Assignor's Interest
Apr 2, 2009
From: WANG, BING; WALKINSHAW, GAIL
To: GALILEO LABORATORIES, INC.
Reel/Frame 022496/0254 →
Change of Name
Apr 2, 2009
From: GALILEO LABORATORIES, INC.
To: GALILEO PHARMACEUTICALS, INC.
Reel/Frame 022505/0467 →
Assignment of Assignor's Interest
Apr 15, 2009
From: WANG, BING; CHEN, JIAN
To: GALILEO PHARMACEUTICALS, INC.
Reel/Frame 022548/0886 →
Assignment of Assignor's Interest
Apr 15, 2009
From: GALILEO PHARMACEUTICALS, INC.
To: EDISON PHARMACEUTICALS, INC.
Reel/Frame 022548/0950 →
Assignment of Assignor's Interest
Nov 9, 2009
From: MILLER, GUY M.; KHEIFETS, VIKTORIA
To: EDISON PHARMACEUTICALS, INC.
Reel/Frame 023492/0549 →
Assignment of Assignor's Interest
Dec 30, 2009
From: WESSON, KIERON E.; HINMAN, ANDREW W.; JANKOWSKI, ORION D.
To: EDISON PHARMACEUTICALS, INC.
Reel/Frame 023721/0621 →